Table 1.
Hormonal features of the patient with testotoxicosis at diagnosis.
| Detection value | Normal range | |
|---|---|---|
| Basic LH (IU/L) | 0.25 | |
| Basic FSH (IU/L) | 0.37 | |
| Peak LH (IU/L) | 2.66 | |
| Peak FSH (IU/L) | 1.03 | |
| total testosterone (ng/dl) | 231 | <20 |
| Androstenedione (μg/L) | <0.3 | 0.7-3.6 |
| dehydroepiandrosterone sulfate (μg/dL) | <15 | 80-560 |
| sex hormone binding globulin | 80.1 | 13-71 |
| Progesterone (μg/L) | 1.18 | 0-1.4 |
| 17-alpha-hydroxyprogesterone (nmol/L) | 2.0 | 0-30 |
| human chorionic gonadotrophin (U/L) | 0.91 | 0.4-5.0 |
| Thyrotropin (U/L) | 0.91 | 0.4-5.0 |
| Free triiodothyronine (ng/L) | 3.10 | 1.5-4.1 |
| Free thyroxine (pmol/L) | 21.60 | 8.3-29.6 |
| Adrenergic hormone releasing hormone (ng/L) | 30.2 | 0-46 |
| Cortisol (nmol/L) | 241 | 138-690 |
| Growth hormone (μg/L) | 1.95 | |
| Insulin - like growth factor-1 (μg/L) | 363 | 49-297 |
LH: luteinizing hormone; FSH: follicle-stimulating hormone; Peak LH value and peak FSH value were measured after exogenous intravenous administration of luteinizing−hormone releasing hormone (2.5ug/kg).